Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses what new therapies are emerging in the world of pain management.
Transcript:
Are there any newer therapies for pain on the horizon that you are keeping an eye on?
Well, there's a number of them and the evidence is growing more and more for these. For those that are interested in, in kind of keeping up with what is reaching the level of sufficient evidence to consider for your own practice. I would urge you to look at the VA's Whole Health website, where they have a list of currently recommended approaches for chronic illness many of which are for chronic pain.
[Some] CME [continuing medical education] courses list current approaches that now have sufficient evidence to consider for everybody to put into these areas.
I know there are also increasing approaches to chronic pain with new drugs, for example, ketamine. But ketamine has great addictive potential and it can be used only cautiously in certain types of patients, chronic regional pain syndrome, for example, and some types of neuropathy. It needs to be used carefully. Most of the time has to be given [intravenous] in the office.
So, there these are new therapies that are of interest, but they need to be used appropriately based on good evidence and integrated with the leading components for chronic pain management that impact patients in the long run, which are the behavior, lifestyle, and nonpharmacological approaches.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More